Abstract
Recent epidemiological studies in the United States estimate the prevalence of the FMR1 premutation as ranging from 1/148 to 1/209 in women and from 1/290 to 1/468 in men, with greater variability in prevalence reported in studies internationally. Population studies investigating the prevalence of FXTAS in the general population have not been conducted due to the rarity of the disorder. The prevalence of FXTAS is estimated to be 1/4000 in men over the age of 55, due to age-dependent penetrance. The prevalence in women is thought to be much lower, at approximately 1/7800, because of the protection of the second X chromosome. Many screening studies have been conducted in movement disorder populations, attempting to ascertain undiagnosed FXTAS cases and premutation expansions. These studies have yielded low rates, with a rate of 1 % in cerebellar ataxia patients, <1 % in parkinsonian disorders, such as Parkinson disease and multiple system atrophy, and 0 % in essential tremor. Screening studies vary widely in the type of patients included, both in ethnicity and in gender. Wider inclusion criteria for screening could increase the rates of ascertainment of both FXTAS and premutation expansions in future studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams SA, Steenblock KJ, Thibodeau SN, Lindor NM (2008) Premutations in the FMR1 gene are uncommon in men undergoing genetic testing for spinocerebellar ataxia. J Neurogenet 22(1):77–92
Annesi G, Nicoletti G, Tarantino P, Cutuli N, Annesi F, Marco EV, Zappia M, Morgante L, Arabia G, Pugliese P, Condino F, Carrideo S, Civitelli D, Caracciolo M, Romeo N, Spadafora P, Candiano IC, Quattrone A (2004) FRAXE intermediate alleles are associated with Parkinson's disease. Neurosci Lett 368(1):21–24
Berkenstadt M, Ries-Levavi L, Cuckle H, Peleg L, Barkai G (2007) Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests. Prenat Diagn 27(11):991–994
Berry-Kravis E, Potanos K, Weinberg D, Zhou L, Goetz CG (2005) Penetrance of fragile X-associated tremor/ataxia syndrome (FXTAS) in two sisters related to X-inactivation pattern. Ann Neurol 57:144–147
Biancalana V, Toft M, Le Ber I, Tison F, Scherrer E, Thibodeau S, Mandel JL, Brice A, Farrer MJ, Durr A (2005) FMR1 premutations associated with fragile X-associated tremor/ataxia syndrome in multiple system atrophy. Arch Neurol 62(6):962
Brusse E, Maat-Kievit JA, Van Swieten JC (2007) Diagnosis and management of early- and late-onset cerebellar ataxia. Clin Genet 71(1):12–24
Brussino A, Gellera C, Saluto A, Mariotti C, Arduino C, Castelloti B, Camerlingo M, De Angelis V, Orsi L, Tosca P, Migone N, Taroni F, Brusco A (2005) FMR1 gene premutation is a frequent cause of late-onset sporadic cerebellar ataxia. Neurology 64:145–147
Cilia R, Kraff J, Canesi M, Pezzoli G, Goldwurm S, Amiri K, Tang HT, Pan R, Hagerman PJ, Tassone F (2009) Screening for the presence of FMR1 premutation alleles in women with parkinsonism. Arch Neurol 66(2):244–249
Clark LN, Ye X, Liu X, Louis ED (2015) Genetic analysis of FMR1 repeat expansion in essential tremor. Neurosci Lett 593:114–117
Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ (2008) Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 146A(8):1009–1016
Deng H, Le W, Jankovic J (2004) Premutation alleles associated with Parkinson disease and essential tremor. JAMA 292:1685–1688
Dombrowski C, Lévesque S, Morel MI, Rouillard P, Morgan K, Rousseau F (2002) Premutation and intermediate-size FMR1 alleles in 10,572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11(4):371–378
Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, Pan R, Hagerman P, Tassone F (2009) Screening for expanded alleles for the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn 11(4):371–378
Garcia Arocena D, Louis ED, Tassone F, Gilliam TC, Ottman R, Jacquemont S, Hagerman PJ (2004) Screen for expanded FMR1 alleles in patients with essential tremor. Mov Disord 19(8):930–947
Garland EM, Vnencak-Jones CL, Biaggioni I, Davis TL, Montine TJ, Robertson D (2004) Fragile X gene premutation in multiple system atrophy. J Neurol Sci 227:115–118
Geva E, Yaron Y, Shomrat R, Ben-Yehuda A, Zabari S, Peretz H, Naiman T, Yeger H, Orr-Urtreger A (2000) The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families. Genet Test 4(3):289–292
Hagerman PJ (2008) The fragile X prevalence paradox. J Med Genet 45(8):498–499
Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardini T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ (2004) Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74(5):1051–1056
Hall DA, Berry-Kravis E, Jacquemont S, Rice CD, Cogswell JB, Zhang L (2005) Prior diagnoses given to persons with the Fragile X-associated tremor/ataxia syndrome. Neurology 65:299–301
Hall DA, Hagerman RJ, Hagerman PJ, Jacquemont S, Leehey MA (2006) Prevalence of FMR1 repeat expansions in movement disorders: a systematic review. Neuroepidemiology 26:151–155
Hall DA, Howard K, Hagerman RJ, Leehey MA (2009) Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism Relat Disord 15:156–159
Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MA (2011) FMR1 gray-zone alleles: association with Parkinson's disease in women? Mov Disord 26(10):1900–1906
Hedrich K, Pramstaller PP, Stübke K, Hiller A, Kabakci K, Purmann S, Kasten M, Scaglione C, Schwinger E, Volkmann J, Kostic V, Vieregge P, Martinelli P, Abbruzzese G, Klein C, Zühlke C (2005) Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease? Mov Disord 20(8):1060–1062
Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ (2004) Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. J Am Med Assoc 291(4):460–469
Jacquemont S, Leehey MA, Hagerman RJ, Beckett LA, Hagerman PJ (2006) Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet 43(10):804–809
Kamm C, Healy DG, Quinn NP, Wüllner U, Moller JC, Schols L, Geser F, Burk K, Børglum AD, Pellecchia MT, Tolosa E, del Sorbo F, Nilsson C, Bandmann O, Sharma M, Mayer P, Gasteiger M, Haworth A, Ozawa T, Lees AJ, Short J, Giunti P, Holinski-Feder E, Illig T, Wichmann HE, Wenning GK, Wood NW, Gasser T, European Multiple System Atrophy Study Group (2005) The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain 128:1855–1860
Kerber KA, Jen JC, Perlman S, Baloh RW (2005) Late-onset pure cerebellar ataxia: differentiating those with and without identifiable mutations. J Neurol Sci 238:41–45
Kraff J, Tang HT, Cilia R, Canesi M, Pezzoli G, Goldwurm S, Hagerman PJ, Tassone F (2007) Screen for excess FMR1 premutation alleles among males with parkinsonism. Arch Neurol 64(7):1002
Kraft S, Furtado S, Ranawaya R, Parboosingh J, Bleoo S, Mcelligott K, Bridge P, Spacey S, Das S, Suchowersky O (2005) Adult onset spinocerebellar ataxia in a Canadian movement disorders clinic. Can J Neurol Sci 32(4):450–458
Leehey MA, Berry-Kravis E, Goetz C, Zhang L, Hall DA, Li L, Rice CD, Lara R, Cogswell JB, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman RJ (2008) FMR1 CGG repeat length predicts motor dysfunction in FXTAS. Neurology 70:1397–1402
Macpherson J, Waghorn A, Hammans S, Jacobs P (2003) Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet 112:619–620
Maenner MJ, Baker MW, Broman KW, Tian J, Barnes JK, Atkins A, Mcpherson E, Hong J, Brilliant MH, Mailick MR (2013) FMR1 CGG expansions: prevalence and sex ratios. Am J Med Genet B Neuropsychiatr Genet 162B(5):466–473
Milunsky JM, Maher TA (2004) Fragile X carrier screening and spinocerebellar ataxia in older males. Am J Med Genet A 125A:320
Rajkiewicz M, Sulek-Piatkowska A, Krysa W, Zdzienicka E, Szirkowiec W, Zaremba J (2008) Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. Neurol Neurochir Pol 42(6):497–504
Reis AH, Ferreira AC, Gomes KB, Aguiar MJ, Fonseca CG, Cardoso FE, Pardini VC, Carvalho MR (2008) Frequency of FMR1 premutation in individuals with ataxia and/or tremor and/or parkinsonism. Genet Mol Res 7(1):74–84
Rife M, Badenas C, Mallolas J, Jimenez L, Cervera R, Maya A, Glover G, Rivera F, Mila M (2003) Incidence of fragile X in 5,000 consecutive newborn males. Genet Test 7(4):339–343
Rodriguez-Revenga L, Gómez-Anson B, Muñoz E, Jiménez D, Santos M, Tintoré M, MartÃn G, Brieva L, Milà M (2007) FXTAS in spanish patients with ataxia: support for female FMR1 premutation screening. Mol Neurobiol 35(3):324–328
Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K (1995) Prevalence of carriers of premutation-size alleles of the FMRI gene—and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57(5):1006–1018
Ryynanen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K (1999) Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 7(2):212–216
Saul RA, Friez M, Eaves K, Stapleton GA, Collins JS, Schwartz CE, Stevenson RE (2008) Fragile X syndrome detection in newborns-pilot study. Genet Med 10(10):714–719
Seixas AI, Maurer MH, Lin M, Callahan C, Ahuja A, Matsuura T, Ross CA, Hisama FM, Silveira I, Margolis RL (2005) FXTAS, SCA10, and SCA17 in American patients with movement disorders. Am J Med Genet A 136(1):87–89
Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg J, Mandel D (2012) Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet B Neuropsychiatr Genet 159B(5):589–597
Tan EK, Zhao Y, Puong KY, Law HY, Chan LL, Yew K, Tan C, Shen H, Chandran VR, Teoh ML, Yih Y, Pavanni R, Wong MC, Ng IS (2004) Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 63:362–363
Tan EK, Zhao Y, Puong KY, Law HY, Chan LL, Yew K, Shen H, Chandran VR, Yuen Y, Pavanni R, Wong MC, Ng IS (2005) Expanded FMR1 alleles are rare in idiopathic Parkinson's disease. Neurogenetics 6(1):51–52
Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, Li L, Hagerman RJ, Hagerman PJ (2007) CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet 144B(4):566–569
Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman RJ (2012) FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 4(12):100
Toft M, Aasly J, Bisceglio G, Adler CH, Uitti RJ, Krygowska-Wajs A, Lynch T, Wszolek ZK, Farrer MJ (2005) Parkinsonism, FXTAS, and FMR1 premutations. Mov Disord 20(2):230–233
Toledano-Alhadef H, Basel-Vanagaite L, Magal N, Davidov B, Ehrlich S, Drasinover V, Taub E, Halpern GJ, Ginott N, Shohat M (2001) Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet 69(2):351–360
Van Esch H, Dom R, Bex D, Salden I, Caeckebeke J, Wibail A, Borghgraef M, Leguis E, Fryns J, Matthijs G (2005) Screening for FMR1 premutations in 122 older Flemish males presenting with ataxia. Eur J Hum Genet 13:121–123
Yabe I, Soma H, Takei A, Fujik N, Sasaki H (2004) No association between FMR1 premutations and multiple system atrophy. J Neurol 251(11):1411–1412
Zühlke C, Budnik A, Gehlken U, Dalski A, Purmann S, Naumann M, Schmidt M, Bürk K, Schwinger E (2004) FMR1 premutation as a rare cause of late onset ataxia—evidence for FXTAS in female carriers. J Neurol 251(11):1418–1419
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hall, D.A., Mailick, M. (2016). The Epidemiology of FXTAS. In: Tassone, F., Hall, D. (eds) FXTAS, FXPOI, and Other Premutation Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-33898-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-33898-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33896-5
Online ISBN: 978-3-319-33898-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)